Second Insider, Same Price. Healthcare Headwinds Persist.
CEO Jeffrey Simmons just bought $99,843 worth of ELAN at $20.09, matching almost exactly the $99,939 buy from another insider earlier today. That's two C-suite players stepping in at the same price level while the stock sits oversold with RSI at 35. The technicals are ugly though. All timeframes flashing sell signals, and insiders on this name have struggled historically with only a 43% win rate over 90 days.
The Filing
| Ticker | ELAN |
| Company | Elanco Animal Health Inc |
| Insider | Jeffrey Simmons, PRESIDENT, CEO AND DIRECTOR |
| Buy amount | $99,843 |
| Filing date | May 19, 2026 |
| Conviction | Interesting · 54/100 |
| Setup type | Oversold Bounce |
Ultimate members received this analysis in real time.